Amgen

Open: 255.75 Close: 259.43 Change: 3.68

How to get information about Amgen without reading the whole internet.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Horizon, FTC, Therapeutics, agreement, consent, lawsuit, and the most common words in the summary are: amgen, kidney, job, market, best, stock, disease, . One of the sentences in the summary was: FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics. Other searches related …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics. FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would stifle competition in the pharmaceutical industry. Amgen is to be barred from leveraging its drug portfolio to disadvantage its industry competitors.

Today's News

Amgen and Horizon Therapeutics have reached a consent order agreement with the Federal Trade Commission to resolve an ongoing administrative lawsuit. Amgen reached an agreement to acquire Horizon in December last year. The FTCs lawsuit against Amgen in May was the agencys first legal challenge to a pharmaceutical buyout in 14 years. The settlement agreement prohibits Amgen from bundling any of its products with two of Horizons blockbuster drugs, among other restrictions. Amgen announced the settlement to end the suit, saying it “will have no impact on Amgens business’s business” The FTC had sued to block Amgen from acquiring Horizon Therapeutics, even though the merger did not fit the usual FTC criteria for preventing such a deal. Horizon Therapeutics deal expected to close early in the fourth quarter. Horizon offers Amgen potentially a better tax jurisdiction related to Irish manufacturing plants... Amgen has a new manufacturing process they could potentially move there FTC, Amgen Reach Settlement on Dispute on Disputes Over Horizon Therapeutics Acquisition. Amgen will be prohibited from entering into a buyout agreement without FTC consent and bundling products with Tepezza. Amgen is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin or disability status. The FTC and several states settled their challenge of Amgens acquisition of Horizon last Friday. Both Amgen and Horizon are large pharmaceutical companies. Amgen Inc. (AMGN) stock price, quote & news - stock analysis. As a Specialty Representative, you will act as the primary customer contact for demand creation. FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics. FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would stifle competition in the pharmaceutical industry. Amgen will present at the 2023 Wells Fargo Healthcare Conference at 9:30 a.m. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. Amgen has a reputation for attracting the best talent around. The employee data is based on information from people who have self-reported their past or current employments at Amgen. HSBC Initiates Coverage of AMGEN (AMGN) with Buy Recommendation HSBC Initiated Coverage of Amgen (AMgn) Fintel reports that on September 6, 2023,HSBC initiated coverage of AMgen with a Buy recommendation. Amgen to present at Morgan Stanley Global Healthcare Conference at 8:50 a.m. ET. Amgen is to be barred from leveraging its drug portfolio to disadvantage its industry competitors. FTC settled on a proposed consent order with Amgen Inc. to address the potential competitive harm Amgen could bring. Your efforts will involve generating clinical demand, facilitating local access, and engaging in formulary, pathway, and funding initiatives. Vast opportunities to learn and move up and across our global organization.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Horizon, FTC, Therapeutics, agreement, consent, lawsuit, and the most common words in the summary are: amgen, kidney, job, market, best, stock, disease, . One of the sentences in the summary was: FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #kidney #job #market #best #stock #disease.